BIOMARKER:

MYC rearrangement

Entrez ID:

Related biomarkers:

‹

›

MYC rearrangement MYC rearrangement	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	lenalidomide Sensitive: B - Late Trials
MYC rearrangement MYC rearrangement	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	lisocabtagene maraleucel Sensitive: C2 – Inclusion Criteria
MYC rearrangement MYC rearrangement	Lymphoma Lymphoma	multiplex silenced CAR-T therapy Resistant: C3 – Early Trials
MYC rearrangement MYC rearrangement	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	EPOCH-R Sensitive: C3 – Early Trials
MYC rearrangement MYC rearrangement	Mediastinal B Cell Lymphoma Mediastinal B Cell Lymphoma	rituximab Sensitive: C3 – Early Trials
MYC rearrangement MYC rearrangement	Follicular Lymphoma Follicular Lymphoma	EPOCH-R Sensitive: C3 – Early Trials
MYC rearrangement MYC rearrangement	Non-Hodgkin’s Lymphoma NHL	CARMEN Sensitive: C3 – Early Trials
MYC rearrangement MYC rearrangement	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	INCB57643 Sensitive: D – Preclinical